Position in GYRE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$316
+$219 QoQ
Shares Held
48
+242.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 60 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Covestor Ltd holds $4,614,670 across 167 Biotechnology names. GYRE ranks #98 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
6,774 | $902,703 | |
| 2 | PRTA |
Prothena Corp Public Ltd Co
|
25,190 | $246,610 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,528 | $187,302 | |
| 4 | INCY |
Incyte Corp
|
1,629 | $184,663 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
493 | $183,233 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
368 | $182,796 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
936 | $175,294 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
2,093 | $155,886 |
All Filings in GYRE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316 | 48 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $97 | 14 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $42 | 6 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $44 | 6 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $44 | 6 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $54 | 7 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $84 | 7 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $75 | 6 | Shares | Sole | 2024-11-01 | |
| No filing history on record for this holder in this stock. | ||||||